Get Premium to unlock powerful stock data
NAS:TMDX (USA)  
TransMedics Group Inc logo

TransMedics Group Inc

$ 31.97 +0.52 (+1.65%) 08:08 PM EST
P/E:
At Loss
P/B:
14.93
Market Cap:
$ 894.55M
Enterprise V:
$ 867.73M
Volume:
142.12K
Avg Vol (2M):
320.02K
Volume:
142.12K
Market Cap $:
894.55M
PE Ratio:
At Loss
Avg Vol (2-Month):
320.02K
Enterprise Value $:
867.73M
PB Ratio:
14.93
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

TransMedics Group Inc
NAICS : 334510 SIC : 3845
200 Minuteman Road, Andover, MA, USA, 01810
Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body.
Name Current Vs Industry Vs History
Cash-To-Debt 1.59
Equity-to-Asset 0.48
Debt-to-Equity 0.75
Debt-to-EBITDA -1.1
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.26
Distress
Grey
Safe
Beneish M-Score -2.23
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 70.48
9-Day RSI 65.84
14-Day RSI 62.48
6-1 Month Momentum % 46.76
12-1 Month Momentum % -17.27

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.22
Quick Ratio 4.4
Cash Ratio 3.55
Days Inventory 489.11
Days Sales Outstanding 66.25
Days Payable 109.43

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13

Financials (Next Earnings Date:2022-08-05 Est.)

TMDX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:TMDX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 39.089
EPS (TTM) ($) -1.7
Beta 1.76
Volatility % 80.57
14-Day RSI 62.48
14-Day ATR ($) 2.175916
20-Day SMA ($) 28.849
12-1 Month Momentum % -17.27
52-Week Range ($) 10 - 35.37
Shares Outstanding (Mil) 27.98

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

TransMedics Group Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More